Active ingredient
Vimseltinib
3 finished FDA listings contain Vimseltinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- VIMSELTINIB
- Dosage forms
- Capsule
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 14 mg/1 · 20 mg/1 · 30 mg/1
- Brand names in FDA listings
- Romvimza
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2705378
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 219304 | DECIPHERA PHARMS | 2025-02-14 | 3 |
Official labeling on DailyMed
- ROMVIMZA (VIMSELTINIB) CAPSULE [DECIPHERA PHARMACEUTICALS, LLC] · version 3 · 2026-07-01
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.